Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$50.44−1.81 (-3.46%)
Close on Nov 13, 2026Market cap $3.60BP/E –Yield –
Pulse Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
Pulse Biosciences's operating margin for the twelve months ending Sep 30, 2026 was -5821.1%. For fiscal 2025 it was -21982.6%, against -8293.9% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -21982.6% | −13688.7 |
| FY2022 | Dec 31, 2022 | -8293.9% | −3850.0 |
| FY2021 | Dec 31, 2021 | -4443.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -6149.9% | +17532.7 |
| Q2 FY2026 | Jun 30, 2026 | -5823.0% | −534.7 |
| Q1 FY2026 | Mar 31, 2026 | -4775.6% | −885.2 |
| Q4 FY2025 | Dec 31, 2025 | -6914.0% | −5088.2 |
| Q3 FY2025 | Sep 30, 2025 | -23682.6% | −21196.0 |
| Q2 FY2022 | Jun 30, 2022 | -5288.3% | – |
| Q1 FY2022 | Mar 31, 2022 | -3890.3% | – |
| Q4 FY2021 | Dec 31, 2021 | -1825.8% | – |
| Q3 FY2021 | Sep 30, 2021 | -2486.6% | – |
See a number that looks wrong?